Shahram S Gholami, MD
Urology · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 20
- 5 carriers
- Office
- 1
Offices
1 location · El Camino Health Medical Network LLC · 202 clinicians in this group
Hospitals listed: El Camino Health · Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
20 plans · 5 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Gholami’s office at (408) 871-5220 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
20 of 20 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
California Medical Board record
Licence A65099 · Current
Licensed to practise in California · since 1998 · expires 2028-01-31 · Boston University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$910,597
Medicare paid this office $910,597 for 638 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 547 | $196,659 | $114 |
| Complete ultrasound of abdomen and pelvis artery and vein blood flow | 180 | $57,580 | $282 |
| Detection test by nucleic acid for organism, amplified probe technique | 102 | $48,419 | $34 |
| Unclassified drugs | 94 | $41,900 | None |
| Injection, denosumab, 1 mg | 13 | $38,015 | None |
See all 49 services
| Return visit (30+ min) | 547 | $196,659 | $114 |
| Complete ultrasound of abdomen and pelvis artery and vein blood flow | 180 | $57,580 | $282 |
| Detection test by nucleic acid for organism, amplified probe technique | 102 | $48,419 | $34 |
| Unclassified drugs | 94 | $41,900 | None |
| Injection, denosumab, 1 mg | 13 | $38,015 | None |
| Detection test by nucleic acid for multiple organisms, amplified probe(s) technique | 102 | $35,744 | $69 |
| Long return visit (40+ min) | 153 | $35,591 | $166 |
| Complete ultrasound scan of pelvis | 204 | $28,816 | $108 |
| Complex measurement of pressure of urine flow in bladder with voiding pressure studies | 44 | $17,771 | $378 |
| Placement of hormone pellet under skin | 95 | $16,886 | $90 |
| Diagnostic exam of bladder and urethra using an endoscope | 51 | $16,157 | $245 |
| Complete ultrasound scan behind abdominal cavity | 125 | $15,996 | $111 |
| Ultrasound measurement of bladder capacity after voiding | 544 | $15,496 | $12 |
| Complete laser fragmentation of prostate including control of bleeding using an endoscope | 21 | $14,652 | $698 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 15 | $14,433 | None |
| Short return visit (20+ min) | 99 | $14,330 | $81 |
| Ultrasound scan of pelvic region through rectum | 89 | $13,383 | $147 |
| New patient visit (45+ min) | 79 | $11,561 | $146 |
| Insertion of needle or tube into prostate for radiation therapy | 15 | $10,092 | $673 |
| Irrigation and removal of multiple blood clots from bladder and urethra using an endoscope | 20 | $9,735 | $423 |
| Biopsy of prostate gland | 38 | $8,648 | $228 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 333 | $8,142 | $15 |
| New patient visit (60+ min) | 34 | $6,451 | $190 |
| Detection of mycoplasma genitalium by dna or rna probe | 102 | $6,121 | $34 |
| Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique | 102 | $6,053 | $34 |
| Detection test by nucleic acid for neisseria gonorrhoeae (gonorrhoeae bacteria), amplified probe technique | 102 | $6,053 | $34 |
| Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique | 102 | $6,053 | $34 |
| Detection test by nucleic acid for staphylococcus aureus, methicillin resistant (mrsa bacteria), amplified probe technique | 102 | $6,053 | $34 |
| Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique | 102 | $6,053 | $34 |
| Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique | 102 | $6,053 | $34 |
| Detection test by nucleic acid for trichomonas vaginalis (genital parasite), amplified probe technique | 102 | $6,053 | $34 |
| Detection test for candida species (yeast), amplified probe technique | 102 | $6,053 | $34 |
| Detection test by nucleic acid for chlamydia trachomatis, amplified probe technique | 102 | $6,053 | $34 |
| Ultrasound of abdomen and pelvis artery and vein blood flow | 37 | $4,840 | $131 |
| Urinalysis, manual test | 508 | $4,210 | $3 |
| Complicated insertion of bladder tube | 13 | $4,180 | $144 |
| New patient visit (30+ min) | 21 | $2,252 | $107 |
| Detection test for gardnerella vaginalis (bacteria), amplified probe technique | 27 | $1,960 | $34 |
| Simple insertion of temporary bladder tube | 17 | $1,410 | $64 |
| Manual urinalysis test with examination using microscope, non-automated | 221 | $1,170 | $4 |
| Ultrasound scan of scrotum | 12 | $1,161 | $97 |
| Exam of vagina and cervix using an endoscope | 14 | $1,032 | $65 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 16 | $861 | $37 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 17 | $696 | $39 |
| Limited ultrasound scan of pelvis | 14 | $688 | $46 |
| Other procedure on urinary system | 27 | $563 | $21 |
| Electronic assessment of bladder emptying | 41 | $420 | $10 |
| Injection of drug or substance under skin or into muscle | 13 | $300 | $13 |
| Injection procedure for imaging of bladder during voiding | 14 | $264 | $19 |
Procedures Medicare counted
| Prostate resection | 68 | More than 98% of doctors who do this |
Who their Medicare patients are
638 Original Medicare patients in 2024. Average age 77 · Women 17% · Also on Medicaid 5% · Health risk score 1.18. At or below the middle of the specialty; the typical urology clinician is at 1.36.
Conditions among them: High blood pressure 75% · Coronary heart disease 39% · Cancer 38% · Diabetes 31% · Chronic kidney disease 26% · Atrial fibrillation 22% · Heart failure 14% · Depression 14% · Stroke 11% · COPD 9% · Dementia 8%.
The office billed $3,422,202, Medicare allowed $1,132,916 and paid $910,597; for 16,029 services of 123 kinds; $104,929 of it was for drugs given in the office and $805,668 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 638 | 16,029 | 77 | 1.18 | $3,422,202 | $910,597 |
| 2023 | 643 | 14,011 | 76 | 1.07 | $2,741,722 | $1,159,821 |
| 2022 | 626 | 9,543 | 77 | 1.15 | $2,499,592 | $1,029,954 |
| 2021 | 630 | 8,431 | 77 | 1.15 | $2,297,830 | $877,912 |
| 2020 | 548 | 8,201 | 76 | 1.17 | $2,042,076 | $757,603 |
| 2019 | 555 | 10,032 | 76 | 1.08 | $1,569,984 | $572,150 |
| 2018 | 537 | 6,642 | 76 | 1.19 | $2,035,367 | $836,637 |
| 2017 | 510 | 6,193 | 76 | 1.12 | $2,161,846 | $880,254 |
| 2016 | 532 | 5,144 | 76 | 1.14 | $1,168,822 | $375,392 |
| 2015 | 521 | 4,526 | 75 | 1.11 | $1,174,512 | $386,305 |
| 2014 | 493 | 3,984 | 75 | 1.04 | $842,272 | $287,040 |
| 2013 | 502 | 2,378 | 76 | 0.97 | $759,289 | $261,144 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 52 services
| Return visit (30+ min) | 536 | $144,461 | $106 |
| Unclassified drugs | 81 | $84,906 | None |
| Insertion of implant in urethra within prostate gland using an endoscope, each additional implant | 15 | $75,299 | $965 |
| Detection test by nucleic acid for organism, amplified probe technique | 117 | $54,816 | $34 |
| Detection test by nucleic acid for multiple organisms, amplified probe(s) technique | 116 | $40,132 | $69 |
| Short return visit (20+ min) | 288 | $35,158 | $77 |
| Complete ultrasound scan of pelvis | 215 | $31,422 | $111 |
| Complete ultrasound of abdomen and pelvis artery and vein blood flow | 96 | $28,620 | $281 |
| Complete laser fragmentation of prostate including control of bleeding using an endoscope | 28 | $20,817 | $743 |
| Insertion of implant in urethra within prostate gland using an endoscope, 1 implant | 15 | $20,768 | $1,385 |
| Long return visit (40+ min) | 99 | $19,193 | $159 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 18 | $18,850 | None |
| Ultrasound of abdomen and pelvis artery and vein blood flow | 118 | $18,598 | $151 |
| Complex measurement of pressure of urine flow in bladder with voiding pressure studies | 47 | $18,221 | $380 |
| Placement of hormone pellet under skin | 81 | $15,417 | $90 |
| Complete ultrasound scan behind abdominal cavity | 122 | $15,052 | $115 |
| Diagnostic exam of bladder and urethra using an endoscope | 49 | $14,926 | $245 |
| Ultrasound measurement of bladder capacity after voiding | 562 | $14,872 | $11 |
| New patient visit (60+ min) | 58 | $10,742 | $185 |
| Irrigation and removal of multiple blood clots from bladder and urethra using an endoscope | 17 | $8,566 | $428 |
| Ultrasound scan of pelvic region through rectum | 55 | $8,231 | $147 |
| Detection test for candida species (yeast), amplified probe technique | 117 | $6,775 | $34 |
| Detection test by nucleic acid for chlamydia trachomatis, amplified probe technique | 117 | $6,775 | $34 |
| Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique | 117 | $6,775 | $34 |
| Detection test by nucleic acid for neisseria gonorrhoeae (gonorrhoeae bacteria), amplified probe technique | 117 | $6,775 | $34 |
| Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique | 117 | $6,775 | $34 |
| Detection test by nucleic acid for staphylococcus aureus, methicillin resistant (mrsa bacteria), amplified probe technique | 117 | $6,775 | $34 |
| Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique | 117 | $6,775 | $34 |
| Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique | 117 | $6,775 | $34 |
| Detection test by nucleic acid for trichomonas vaginalis (genital parasite), amplified probe technique | 117 | $6,775 | $34 |
| Manual urinalysis test with examination using microscope, non-automated | 593 | $6,545 | $4 |
| Detection of mycoplasma genitalium by dna or rna probe | 110 | $6,431 | $34 |
| Biopsy of prostate gland | 25 | $6,033 | $241 |
| New patient visit (45+ min) | 43 | $5,579 | $130 |
| Crushing of stone of ureter with insertion of stent using an endoscope | 13 | $4,541 | $324 |
| Complicated insertion of bladder tube | 11 | $3,619 | $151 |
| Simple bladder irrigation and/or instillation | 30 | $2,775 | $77 |
| Injection, phentolamine mesylate, up to 5 mg | 15 | $2,674 | None |
| Detection test for gardnerella vaginalis (bacteria), amplified probe technique | 32 | $1,788 | $34 |
| Short return visit | 27 | $1,556 | $50 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 42 | $1,501 | $34 |
| Ultrasonic guidance for needle placement | 25 | $1,457 | $58 |
| Crushing of stone of ureter using an endoscope | 12 | $1,439 | $111 |
| Injection procedure to cause erection | 18 | $1,419 | $65 |
| Complete ultrasound of penis artery and vein blood flow | 12 | $1,322 | $110 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 22 | $1,000 | $34 |
| Electronic assessment of bladder emptying | 77 | $784 | $9 |
| Limited ultrasound scan of pelvis | 13 | $646 | $50 |
| Removal or manipulation of stone in ureter or kidney using an endoscope | 13 | $628 | $45 |
| Review by radiologist of ureter or urethra image | 13 | $497 | $36 |
| Injection of drug or substance into artery | 15 | $260 | $17 |
| Injection, midazolam hydrochloride, per 1 mg | 15 | $9 | None |
2022: 49 services
| Return visit (30+ min) | 513 | $136,479 | $111 |
| Insertion of implant in urethra within prostate gland using an endoscope, each additional implant | 25 | $133,218 | $1,009 |
| Unclassified drugs | 77 | $76,578 | None |
| Complete ultrasound of abdomen and pelvis artery and vein blood flow | 176 | $56,699 | $279 |
| Insertion of implant in urethra within prostate gland using an endoscope, 1 implant | 25 | $36,023 | $1,441 |
| Short return visit (20+ min) | 247 | $32,897 | $72 |
| Complete ultrasound scan of pelvis | 182 | $25,185 | $110 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 20 | $19,324 | None |
| Long return visit (40+ min) | 89 | $17,220 | $158 |
| Irrigation and removal of multiple blood clots from bladder and urethra using an endoscope | 30 | $14,266 | $408 |
| Ultrasound measurement of bladder capacity after voiding | 544 | $14,143 | $11 |
| Placement of hormone pellet under skin | 76 | $13,655 | $90 |
| Complete ultrasound scan behind abdominal cavity | 107 | $13,170 | $116 |
| Ultrasound scan of pelvic region through rectum | 77 | $12,195 | $142 |
| New patient visit (60+ min) | 54 | $10,176 | $188 |
| Complex measurement of pressure of urine flow in bladder with voiding pressure studies | 24 | $9,881 | $395 |
| Diagnostic exam of bladder and urethra using an endoscope | 32 | $9,150 | $247 |
| Complete laser fragmentation of prostate including control of bleeding using an endoscope | 13 | $9,150 | $704 |
| Detection test by nucleic acid for organism, amplified probe technique | 22 | $8,047 | $34 |
| Biopsy of prostate gland | 30 | $6,736 | $225 |
| New patient visit (45+ min) | 47 | $6,714 | $143 |
| Manual urinalysis test with examination using microscope, non-automated | 573 | $6,494 | $4 |
| Destruction and/or removal of large growth of bladder using an endoscope | 11 | $3,993 | $333 |
| Injection, phentolamine mesylate, up to 5 mg | 15 | $3,156 | None |
| Simple bladder irrigation and/or instillation | 37 | $3,103 | $78 |
| Complicated insertion of bladder tube | 14 | $2,919 | $154 |
| Complete ultrasound of penis artery and vein blood flow | 14 | $2,155 | $113 |
| Injection procedure to cause erection | 16 | $1,659 | $75 |
| Short return visit | 28 | $1,617 | $44 |
| Ultrasonic guidance for needle placement | 27 | $1,576 | $58 |
| Detection test for candida species (yeast), amplified probe technique | 22 | $894 | $34 |
| Detection test by nucleic acid for chlamydia trachomatis, amplified probe technique | 22 | $894 | $34 |
| Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique | 22 | $894 | $34 |
| Detection test by nucleic acid for neisseria gonorrhoeae (gonorrhoeae bacteria), amplified probe technique | 22 | $894 | $34 |
| Detection test by nucleic acid for staphylococcus aureus, methicillin resistant (mrsa bacteria), amplified probe technique | 22 | $894 | $34 |
| Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique | 22 | $894 | $34 |
| Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique | 22 | $894 | $34 |
| Detection test by nucleic acid for trichomonas vaginalis (genital parasite), amplified probe technique | 22 | $894 | $34 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 21 | $874 | $35 |
| Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique | 21 | $860 | $34 |
| Exam of vagina and cervix using an endoscope | 12 | $777 | $60 |
| Limited ultrasound scan of pelvis | 13 | $634 | $49 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 19 | $600 | $32 |
| Electronic assessment of bladder emptying | 50 | $455 | $9 |
| Injection of drug or substance into artery | 20 | $350 | $17 |
| Imaging of urinary tract following injection of a contrast agent | 14 | $318 | $23 |
| Imaging guidance for procedure, 60 minutes or less | 15 | $218 | $14 |
| Injection, phenylephrine hcl, up to 1 ml | 11 | $50 | None |
| Injection, midazolam hydrochloride, per 1 mg | 24 | $15 | None |
2021: 41 services
| Insertion of implant in urethra within prostate gland using an endoscope, each additional implant | 33 | $200,104 | $1,118 |
| Return visit (30+ min) | 516 | $134,768 | $115 |
| Unclassified drugs | 69 | $63,861 | None |
| Complete ultrasound of abdomen and pelvis artery and vein blood flow | 185 | $62,969 | $300 |
| Insertion of implant in urethra within prostate gland using an endoscope, 1 implant | 32 | $49,326 | $1,541 |
| Short return visit (20+ min) | 222 | $29,786 | $82 |
| Complete ultrasound scan of pelvis | 194 | $27,509 | $117 |
| Ultrasound scan of pelvic region through rectum | 131 | $25,852 | $150 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 26 | $25,450 | None |
| Long return visit (40+ min) | 99 | $22,316 | $168 |
| Complete laser fragmentation of prostate including control of bleeding using an endoscope | 22 | $16,068 | $730 |
| Partial removal of kidney using an endoscope | 12 | $14,141 | $1,178 |
| Release of scar tissue at ureter | 15 | $13,124 | $820 |
| Complete ultrasound scan behind abdominal cavity | 92 | $12,372 | $120 |
| Ultrasound measurement of bladder capacity after voiding | 510 | $12,210 | $11 |
| Diagnostic exam of bladder and urethra using an endoscope | 43 | $12,159 | $243 |
| Placement of hormone pellet under skin | 68 | $11,273 | $93 |
| New patient visit (45+ min) | 73 | $10,623 | $146 |
| Removal of stent in ureter through ureter with review by radiologist | 13 | $10,569 | $813 |
| New patient visit (60+ min) | 49 | $9,435 | $193 |
| Biopsy of prostate gland | 34 | $8,429 | $248 |
| Irrigation and removal of multiple blood clots from bladder and urethra using an endoscope | 18 | $8,386 | $399 |
| Insertion of needle or tube into prostate for radiation therapy | 11 | $7,584 | $689 |
| Manual urinalysis test with examination using microscope, non-automated | 556 | $6,332 | $4 |
| Dilation of urethra using an endoscope | 12 | $5,551 | $347 |
| Short return visit | 36 | $3,174 | $48 |
| Injection, phentolamine mesylate, up to 5 mg | 11 | $2,166 | None |
| Simple bladder irrigation and/or instillation | 23 | $2,058 | $82 |
| Ultrasonic guidance for needle placement | 34 | $1,990 | $59 |
| Limited ultrasound scan of pelvis | 31 | $1,822 | $49 |
| Injection procedure to cause erection | 12 | $1,127 | $80 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 26 | $1,039 | $35 |
| Exam of vagina and cervix using an endoscope | 12 | $767 | $59 |
| Ultrasonic guidance for administration of radiation therapy | 11 | $694 | $63 |
| Injection of drug or substance into artery | 33 | $603 | $18 |
| Electronic assessment of bladder emptying | 43 | $601 | $14 |
| Imaging of urinary tract following injection of a contrast agent | 13 | $369 | $23 |
| Imaging guidance for procedure, 60 minutes or less | 16 | $264 | $14 |
| Injection procedure for imaging of bladder during voiding | 11 | $220 | $20 |
| Review by radiologist of urinary bladder image | 11 | $156 | $14 |
| Injection, midazolam hydrochloride, per 1 mg | 33 | $18 | None |
2020: 37 services
| Insertion of implant in urethra within prostate gland using an endoscope, each additional implant | 35 | $216,253 | $1,098 |
| Return visit (30+ min) | 441 | $96,395 | $97 |
| Unclassified drugs | 61 | $60,025 | None |
| Insertion of implant in urethra within prostate gland using an endoscope, 1 implant | 35 | $51,702 | $1,477 |
| Complete ultrasound of abdomen and pelvis artery and vein blood flow | 145 | $47,137 | $289 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 22 | $29,567 | None |
| Short return visit (20+ min) | 203 | $21,373 | $68 |
| Long return visit (40+ min) | 98 | $19,658 | $132 |
| Complete ultrasound scan of pelvis | 138 | $19,517 | $113 |
| Complete laser fragmentation of prostate including control of bleeding using an endoscope | 17 | $11,936 | $702 |
| Placement of hormone pellet under skin | 60 | $10,612 | $91 |
| Complete ultrasound scan behind abdominal cavity | 76 | $10,313 | $119 |
| Ultrasound scan of pelvic region through rectum | 66 | $9,257 | $140 |
| Ultrasound measurement of bladder capacity after voiding | 424 | $8,815 | $10 |
| Insertion of needle or tube into prostate for radiation therapy | 12 | $8,699 | $725 |
| Diagnostic exam of bladder and urethra using an endoscope | 34 | $8,270 | $207 |
| Release of scar tissue at ureter | 11 | $8,074 | $734 |
| New patient visit (45+ min) | 55 | $7,639 | $139 |
| Irrigation and removal of multiple blood clots from bladder and urethra using an endoscope | 13 | $5,879 | $392 |
| Biopsy of prostate gland | 21 | $5,070 | $241 |
| Manual urinalysis test with examination using microscope, non-automated | 485 | $4,839 | $4 |
| New patient visit (60+ min) | 22 | $3,187 | $145 |
| Complicated insertion of bladder tube | 17 | $2,939 | $140 |
| Injection, phentolamine mesylate, up to 5 mg | 11 | $2,812 | None |
| Simple bladder irrigation and/or instillation | 22 | $1,692 | $74 |
| Injection procedure to cause erection | 11 | $1,251 | $83 |
| Short return visit | 24 | $1,215 | $45 |
| Ultrasonic guidance for needle placement | 21 | $1,201 | $57 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 22 | $922 | $33 |
| Ultrasonic guidance for administration of radiation therapy | 12 | $764 | $64 |
| Injection of drug or substance into artery | 34 | $640 | $19 |
| Electronic assessment of bladder emptying | 33 | $416 | $12 |
| Imaging of urinary tract following injection of a contrast agent | 11 | $259 | $24 |
| Injection procedure for imaging of bladder during voiding | 12 | $244 | $20 |
| Imaging guidance for procedure, 60 minutes or less | 13 | $183 | $14 |
| Review by radiologist of urinary bladder image | 12 | $178 | $15 |
| Injection, midazolam hydrochloride, per 1 mg | 34 | $14 | None |
2019: 29 services
| Return visit (30+ min) | 411 | $76,018 | $96 |
| Unclassified drugs | 60 | $70,799 | None |
| Complete ultrasound of abdomen and pelvis artery and vein blood flow | 146 | $45,271 | $287 |
| Short return visit (20+ min) | 315 | $35,791 | $65 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 27 | $33,221 | None |
| Complete ultrasound scan of pelvis | 165 | $20,621 | $109 |
| Complete laser fragmentation of prostate including control of bleeding using an endoscope | 22 | $16,267 | $739 |
| Long return visit (40+ min) | 82 | $13,601 | $131 |
| Placement of hormone pellet under skin | 61 | $12,920 | $90 |
| Ultrasound measurement of bladder capacity after voiding | 433 | $11,538 | $13 |
| New patient visit (45+ min) | 80 | $10,450 | $131 |
| Complete ultrasound scan behind abdominal cavity | 82 | $9,910 | $115 |
| Diagnostic exam of bladder and urethra using an endoscope | 42 | $9,402 | $181 |
| Release of scar tissue at ureter | 11 | $8,585 | $780 |
| Ultrasound scan of pelvic region through rectum | 58 | $7,920 | $130 |
| Biopsy of prostate gland | 31 | $7,633 | $246 |
| Manual urinalysis test with examination using microscope, non-automated | 520 | $5,800 | $4 |
| Irrigation and removal of multiple blood clots from bladder and urethra using an endoscope | 12 | $4,901 | $377 |
| Dilation of urethra using an endoscope | 14 | $4,177 | $298 |
| Short return visit | 60 | $3,671 | $43 |
| New patient visit (60+ min) | 21 | $3,533 | $168 |
| Limited ultrasound scan of pelvis | 52 | $2,743 | $46 |
| Simple bladder irrigation and/or instillation | 21 | $1,919 | $71 |
| Ultrasonic guidance for needle placement | 31 | $1,725 | $56 |
| Complicated insertion of bladder tube | 11 | $1,410 | $117 |
| Injection procedure to cause erection | 11 | $1,258 | $66 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 19 | $1,237 | $32 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 14 | $1,218 | $81 |
| Electronic assessment of bladder emptying | 42 | $542 | $12 |
2018: 31 services
| Return visit (30+ min) | 366 | $67,359 | $91 |
| Insertion of implant in urethra within prostate gland using an endoscope, each additional implant | 11 | $63,096 | $1,034 |
| Unclassified drugs | 61 | $62,016 | None |
| Complete ultrasound of abdomen and pelvis artery and vein blood flow | 132 | $45,218 | $292 |
| Short return visit (20+ min) | 326 | $43,883 | $64 |
| Complete ultrasound scan of pelvis | 175 | $26,363 | $112 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 15 | $24,376 | None |
| Insertion of implant in urethra within prostate gland using an endoscope, 1 implant | 11 | $14,508 | $1,319 |
| Ultrasound measurement of bladder capacity after voiding | 405 | $12,704 | $16 |
| Placement of hormone pellet under skin | 56 | $10,981 | $87 |
| New patient visit (45+ min) | 80 | $10,592 | $132 |
| Complete ultrasound scan behind abdominal cavity | 83 | $10,380 | $115 |
| Complete laser fragmentation of prostate including control of bleeding using an endoscope | 14 | $10,080 | $720 |
| Release of scar tissue at ureter | 12 | $9,161 | $763 |
| Diagnostic exam of bladder and urethra using an endoscope | 47 | $8,568 | $156 |
| Long return visit (40+ min) | 47 | $6,812 | $124 |
| Injection, phentolamine mesylate, up to 5 mg | 16 | $6,805 | None |
| Biopsy of prostate gland | 28 | $6,713 | $240 |
| Ultrasound scan of pelvic region through rectum | 56 | $6,487 | $98 |
| Manual urinalysis test with examination using microscope, non-automated | 504 | $5,710 | $4 |
| Simple bladder irrigation and/or instillation | 33 | $2,828 | $74 |
| New patient visit (60+ min) | 15 | $2,527 | $168 |
| Limited ultrasound scan of pelvis | 46 | $2,445 | $44 |
| Short return visit | 33 | $1,833 | $42 |
| Ultrasonic guidance for needle placement | 29 | $1,763 | $59 |
| Injection procedure to cause erection | 19 | $1,683 | $80 |
| Complete ultrasound of penis artery and vein blood flow | 12 | $1,495 | $125 |
| Electronic assessment of bladder emptying | 47 | $760 | $15 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 13 | $378 | $27 |
| Injection of drug or substance into artery | 11 | $210 | $19 |
| Injection, midazolam hydrochloride, per 1 mg | 15 | $8 | None |
2017: 35 services
| Insertion of implant in urethra within prostate gland using an endoscope, each additional implant | 22 | $93,065 | $1,012 |
| Return visit (30+ min) | 366 | $66,765 | $91 |
| Unclassified drugs | 50 | $51,085 | None |
| Complete ultrasound of abdomen and pelvis artery and vein blood flow | 157 | $50,024 | $287 |
| Destruction of prostate tissue using radiofrequency induced heat | 20 | $37,689 | $1,884 |
| Short return visit (20+ min) | 291 | $34,759 | $65 |
| Insertion of implant in urethra within prostate gland using an endoscope, 1 implant | 22 | $28,422 | $1,292 |
| Release of scar tissue at ureter | 17 | $23,165 | $1,363 |
| Complete ultrasound scan of pelvis | 156 | $22,601 | $111 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 14 | $22,403 | None |
| Complete ultrasound scan behind abdominal cavity | 97 | $11,901 | $116 |
| Ultrasound measurement of bladder capacity after voiding | 333 | $10,960 | $19 |
| Long return visit (40+ min) | 61 | $10,465 | $129 |
| Placement of hormone pellet under skin | 48 | $8,384 | $82 |
| Diagnostic exam of bladder and urethra using an endoscope | 45 | $7,954 | $159 |
| New patient visit (45+ min) | 59 | $7,697 | $130 |
| Surgical removal of prostate and surrounding lymph nodes using an endoscope | 11 | $7,194 | $654 |
| Ultrasound scan of pelvic region through rectum | 72 | $6,962 | $93 |
| Irrigation and removal of multiple blood clots from bladder and urethra using an endoscope | 18 | $6,127 | $340 |
| Manual urinalysis test with examination using microscope, non-automated | 474 | $5,773 | $4 |
| Biopsy of prostate gland | 25 | $5,626 | $225 |
| Complicated repair of wound of scalp, arms, or legs, 1.1-2.5 cm | 13 | $4,259 | $328 |
| Limited ultrasound scan of pelvis | 61 | $3,457 | $47 |
| Simple bladder irrigation and/or instillation | 49 | $3,412 | $66 |
| Dilation of urethra using an endoscope | 11 | $3,253 | $250 |
| New patient visit (60+ min) | 14 | $2,632 | $188 |
| Short return visit | 37 | $2,148 | $41 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 22 | $2,002 | $71 |
| Ultrasonic guidance for needle placement | 26 | $1,591 | $59 |
| Electronic assessment of bladder emptying | 53 | $834 | $15 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 13 | $661 | $31 |
| Injection of drug or substance into artery | 22 | $475 | $19 |
| Imaging of urinary tract following injection of a contrast agent | 15 | $257 | $16 |
| Imaging guidance for procedure, 60 minutes or less | 14 | $116 | $8 |
| Injection, midazolam hydrochloride, per 1 mg | 42 | $19 | None |
2016: 30 services
| Return visit (30+ min) | 375 | $54,790 | $85 |
| Unclassified drugs | 49 | $40,980 | None |
| Short return visit (20+ min) | 261 | $29,962 | $62 |
| Complete ultrasound of abdomen and pelvis artery and vein blood flow | 113 | $24,335 | $199 |
| Complete ultrasound scan of pelvis | 156 | $21,047 | $103 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 13 | $15,809 | None |
| Release of scar tissue at ureter | 15 | $10,872 | $725 |
| New patient visit (45+ min) | 83 | $10,812 | $130 |
| Long return visit (40+ min) | 60 | $9,711 | $123 |
| Diagnostic exam of bladder and urethra using an endoscope | 45 | $9,550 | $184 |
| Complicated repair of wound of scalp, arms, or legs, 1.1-2.5 cm | 27 | $8,769 | $325 |
| Complete ultrasound scan behind abdominal cavity | 76 | $8,485 | $109 |
| Complete laser fragmentation of prostate including control of bleeding using an endoscope | 12 | $8,435 | $703 |
| Ultrasound measurement of bladder capacity after voiding | 288 | $8,321 | $18 |
| Placement of hormone pellet under skin | 49 | $6,658 | $70 |
| Biopsy of prostate gland | 24 | $4,625 | $193 |
| Irrigation and removal of multiple blood clots from bladder and urethra using an endoscope | 12 | $3,982 | $332 |
| Manual urinalysis test with examination using microscope, non-automated | 404 | $3,464 | $4 |
| Dilation of urethra using an endoscope | 13 | $3,422 | $244 |
| Ultrasound scan of pelvic region through rectum | 35 | $3,391 | $89 |
| New patient visit (60+ min) | 17 | $3,093 | $182 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 12 | $2,077 | $173 |
| Ultrasonic guidance for needle placement | 27 | $1,610 | $56 |
| Automated urinalysis test | 238 | $1,056 | $3 |
| Injection procedure to cause erection | 11 | $950 | $79 |
| Short return visit | 15 | $679 | $36 |
| Electronic assessment of bladder emptying | 39 | $667 | $14 |
| Limited ultrasound scan of pelvis | 13 | $623 | $45 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 12 | $384 | $30 |
| Imaging of urinary tract following injection of a contrast agent | 12 | $200 | $15 |
2015: 30 services
| Return visit (30+ min) | 363 | $56,538 | $89 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 21 | $32,546 | None |
| Short return visit (20+ min) | 242 | $27,431 | $65 |
| Complete ultrasound of abdomen and pelvis artery and vein blood flow | 101 | $26,018 | $243 |
| Unclassified drugs | 21 | $20,098 | None |
| Complete ultrasound scan of pelvis | 138 | $18,526 | $107 |
| Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | 28 | $13,967 | $482 |
| Release of scar tissue at ureter | 21 | $13,504 | $643 |
| New patient visit (45+ min) | 86 | $11,332 | $132 |
| Complete laser fragmentation of prostate including control of bleeding using an endoscope | 14 | $10,353 | $739 |
| Diagnostic exam of bladder and urethra using an endoscope | 37 | $8,091 | $188 |
| Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | 11 | $7,654 | $696 |
| Biopsy of prostate gland | 38 | $7,428 | $190 |
| Long return visit (40+ min) | 47 | $7,424 | $128 |
| Irrigation and removal of multiple blood clots from bladder and urethra using an endoscope | 17 | $6,706 | $319 |
| Complete ultrasound scan behind abdominal cavity | 51 | $6,002 | $113 |
| Ultrasound measurement of bladder capacity after voiding | 208 | $5,571 | $19 |
| Ultrasound scan of pelvic region through rectum | 45 | $4,326 | $90 |
| Complicated repair of wound of scalp, arms, or legs, 1.1-2.5 cm | 12 | $4,026 | $336 |
| Placement of hormone pellet under skin | 21 | $3,650 | $76 |
| Automated urinalysis test | 484 | $3,547 | $3 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 15 | $2,865 | $179 |
| New patient visit (60+ min) | 15 | $2,593 | $173 |
| Ultrasonic guidance for needle placement | 39 | $2,294 | $56 |
| Complicated insertion of bladder tube | 11 | $2,215 | $123 |
| Simple repair of surface wound of scalp, neck, underarms, trunk, arms, or legs, 2.5 cm or less | 19 | $1,503 | $42 |
| Cell examination of specimen, selective cellular enhancement technique | 26 | $1,089 | $36 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 21 | $987 | $32 |
| Short return visit | 16 | $692 | $41 |
| Electronic assessment of bladder emptying | 40 | $595 | $15 |
2014: 24 services
| Short return visit (20+ min) | 363 | $40,484 | $62 |
| Return visit (30+ min) | 189 | $26,074 | $94 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 19 | $22,407 | None |
| Complete ultrasound scan of pelvis | 120 | $18,070 | $120 |
| Unclassified drugs | 17 | $15,579 | None |
| Complete ultrasound of abdomen and pelvis artery and vein blood flow | 48 | $14,448 | $273 |
| Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | 14 | $10,128 | $723 |
| New patient visit (45+ min) | 74 | $10,113 | $137 |
| Release of scar tissue at ureter | 13 | $9,633 | $741 |
| Diagnostic exam of bladder and urethra using an endoscope | 40 | $8,289 | $176 |
| Ultrasound of abdomen and pelvis artery and vein blood flow | 38 | $8,069 | $212 |
| Complete ultrasound scan behind abdominal cavity | 47 | $6,592 | $135 |
| Long return visit (40+ min) | 31 | $5,482 | $131 |
| Biopsy of prostate gland | 25 | $5,057 | $202 |
| Placement of hormone pellet under skin | 17 | $4,224 | $94 |
| Ultrasound scan of pelvic region through rectum | 37 | $3,515 | $92 |
| Ultrasound measurement of bladder capacity after voiding | 137 | $3,148 | $19 |
| Automated urinalysis test | 463 | $3,130 | $3 |
| Short return visit | 47 | $2,267 | $39 |
| Simple repair of surface wound of scalp, neck, underarms, trunk, arms, or legs, 2.5 cm or less | 17 | $1,928 | $43 |
| Ultrasonic guidance for needle placement | 26 | $1,894 | $70 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 19 | $830 | $32 |
| Electronic assessment of bladder emptying | 41 | $592 | $14 |
| Limited ultrasound scan of pelvis | 12 | $488 | $41 |
2013: 25 services
| Short return visit (20+ min) | 427 | $50,113 | $62 |
| Unclassified drugs | 16 | $16,190 | None |
| Complete ultrasound scan of pelvis | 108 | $14,813 | $126 |
| New patient visit (45+ min) | 92 | $12,599 | $137 |
| Ultrasound of abdomen and pelvis artery and vein blood flow | 53 | $11,623 | $211 |
| Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | 16 | $11,203 | $700 |
| Complete ultrasound of abdomen and pelvis artery and vein blood flow | 41 | $9,586 | $234 |
| Complete ultrasound scan behind abdominal cavity | 68 | $9,528 | $136 |
| Diagnostic exam of bladder and urethra using an endoscope | 42 | $8,227 | $179 |
| Return visit (30+ min) | 67 | $7,412 | $87 |
| Ultrasonic guidance for needle placement | 22 | $4,931 | $214 |
| Biopsy of prostate gland | 18 | $3,873 | $204 |
| Short return visit | 60 | $3,751 | $39 |
| Limited ultrasound scan of pelvis | 38 | $3,451 | $80 |
| Long return visit (40+ min) | 21 | $2,592 | $113 |
| Placement of hormone pellet under skin | 16 | $2,348 | $94 |
| Ultrasound measurement of bladder capacity after voiding | 88 | $2,164 | $19 |
| Ultrasound scan of pelvic region through rectum | 26 | $1,933 | $72 |
| Limited ultrasound scan behind abdominal cavity | 12 | $1,435 | $110 |
| Injection procedure to cause erection | 13 | $1,166 | $83 |
| Simple repair of surface wound of scalp, neck, underarms, trunk, arms, or legs, 2.5 cm or less | 16 | $1,107 | $44 |
| Cell examination of specimen, selective cellular enhancement technique | 11 | $644 | $54 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 18 | $540 | $19 |
| Electronic assessment of bladder emptying | 29 | $417 | $14 |
| Automated urinalysis test | 82 | $273 | $3 |
Drugs they prescribed that Part D paid
$719,815
Pharmacies billed $719,815 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 1% of their Part D prescriptions (15 of 1,434) in 2024. At or below the middle of the specialty; the typical urology clinician is at 2%.
1,196 generic and fewer than 11 brand-name prescriptions · $719,815 in drug cost · 194 antibiotic prescriptions to 135 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Xtandi | 32 | $358,170 | $11,193 |
| Mounjaro | 80 | $88,835 | $1,110 |
| Gemtesa | 21 | $22,815 | $1,086 |
| Myrbetriq | 20 | $18,504 | $925 |
| Silodosin | 76 | $8,437 | $111 |
See all 25 drugs
| Xtandi | 32 | $358,170 | $11,193 |
| Mounjaro | 80 | $88,835 | $1,110 |
| Gemtesa | 21 | $22,815 | $1,086 |
| Myrbetriq | 20 | $18,504 | $925 |
| Silodosin | 76 | $8,437 | $111 |
| Jardiance | 13 | $7,934 | $610 |
| Tamsulosin | 423 | $7,004 | $17 |
| Eliquis | 11 | $6,579 | $598 |
| Estradiol | 46 | $4,381 | $95 |
| Alfuzosin Hcl Er | 136 | $2,626 | $19 |
| Nitrofurantoin Mono-Macro | 47 | $2,015 | $43 |
| Potassium Citrate Er | 12 | $1,261 | $105 |
| Dutasteride | 21 | $1,128 | $54 |
| Testosterone | 14 | $907 | $65 |
| Tadalafil | 12 | $525 | $44 |
| Finasteride | 27 | $511 | $19 |
| Escitalopram | 26 | $478 | $18 |
| Eplerenone | 12 | $407 | $34 |
| Ciprofloxacin | 101 | $407 | $4 |
| Bicalutamide | 16 | $369 | $23 |
| Bumetanide | 12 | $210 | $18 |
| Metformin | 35 | $172 | $5 |
| Cephalexin | 15 | $122 | $8 |
| Hydrocodone-Acetaminophen | 13 | $83 | $6 |
| Sulfamethoxazole-Trimethoprim | 16 | $55 | $3 |
Year by year
| 2024 | 1,434 | 389 | 1% (15) | None | $719,815 |
| 2023 | 1,639 | 438 | 2% (32) | 13% | $600,345 |
| 2022 | 1,506 | 399 | None | 10% | $339,870 |
| 2021 | 1,564 | 388 | 1% (20) | 6% | $260,095 |
| 2020 | 1,419 | 357 | 1% (17) | None | $131,982 |
| 2019 | 1,480 | 357 | 2% (24) | 11% | $243,977 |
| 2018 | 1,574 | 352 | 1% (22) | 19% | $405,011 |
| 2017 | 1,754 | 327 | 4% (61) | 20% | $370,190 |
| 2016 | 1,839 | 336 | 2% (30) | None | $375,000 |
| 2015 | 1,728 | 330 | 2% (30) | None | $193,104 |
| 2014 | 1,631 | 301 | 2% (36) | None | $164,647 |
| 2013 | 1,331 | 272 | 2% (22) | None | $122,693 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 26 drugs
| Xtandi | 28 | $417,296 | $14,903 |
| Mounjaro | 21 | $27,286 | $1,299 |
| Myrbetriq | 20 | $18,080 | $904 |
| Ozempic | 13 | $12,069 | $928 |
| Gemtesa | 13 | $11,514 | $886 |
| Elmiron | 14 | $11,489 | $821 |
| Tamsulosin | 419 | $9,770 | $23 |
| Silodosin | 82 | $9,131 | $111 |
| Xyosted | 12 | $8,079 | $673 |
| Alfuzosin Hcl Er | 170 | $5,435 | $32 |
| Nitrofurantoin Mono-Macro | 70 | $5,238 | $75 |
| Estradiol | 46 | $4,762 | $104 |
| Ciprofloxacin | 236 | $1,532 | $6 |
| Dutasteride | 24 | $1,097 | $46 |
| Nitrofurantoin | 11 | $636 | $58 |
| Testosterone | 11 | $635 | $58 |
| Eplerenone | 12 | $627 | $52 |
| Escitalopram | 20 | $550 | $28 |
| Metformin | 45 | $450 | $10 |
| Finasteride | 18 | $407 | $23 |
| Bicalutamide | 14 | $298 | $21 |
| Hydrocodone-Acetaminophen | 29 | $221 | $8 |
| Bumetanide | 12 | $208 | $17 |
| Amoxicillin-Clavulanate Potass | 20 | $195 | $10 |
| Cephalexin | 18 | $189 | $11 |
| Sulfamethoxazole-Trimethoprim | 33 | $163 | $5 |
2022: 21 drugs
| Xtandi | 15 | $196,210 | $13,081 |
| Myrbetriq | 26 | $23,946 | $921 |
| Tamsulosin | 466 | $8,512 | $18 |
| Alfuzosin Hcl Er | 213 | $7,035 | $33 |
| Nitrofurantoin Mono-Macro | 87 | $6,106 | $70 |
| Silodosin | 58 | $4,653 | $80 |
| Estradiol | 36 | $4,158 | $116 |
| Tadalafil | 13 | $2,553 | $196 |
| Eplerenone | 12 | $1,063 | $89 |
| Nitrofurantoin | 13 | $1,038 | $80 |
| Estradiol (Twice Weekly) | 11 | $757 | $69 |
| Ciprofloxacin | 152 | $755 | $5 |
| Finasteride | 24 | $610 | $25 |
| Dutasteride | 14 | $568 | $41 |
| Bumetanide | 13 | $343 | $26 |
| Bicalutamide | 19 | $302 | $16 |
| Cephalexin | 29 | $227 | $8 |
| Metformin | 27 | $200 | $7 |
| Escitalopram | 19 | $169 | $9 |
| Sulfamethoxazole-Trimethoprim | 30 | $133 | $4 |
| Allopurinol | 12 | $127 | $11 |
2021: 18 drugs
| Myrbetriq | 17 | $17,279 | $1,016 |
| Alfuzosin Hcl Er | 274 | $10,181 | $37 |
| Tamsulosin | 437 | $9,623 | $22 |
| Tadalafil | 29 | $6,356 | $219 |
| Silodosin | 51 | $4,939 | $97 |
| Nitrofurantoin Mono-Macro | 78 | $4,165 | $53 |
| Estradiol | 14 | $1,914 | $137 |
| Testosterone | 11 | $1,638 | $149 |
| Dutasteride | 21 | $1,127 | $54 |
| Progesterone | 30 | $825 | $27 |
| Ciprofloxacin | 179 | $769 | $4 |
| Bicalutamide | 30 | $685 | $23 |
| Finasteride | 26 | $659 | $25 |
| Cephalexin | 45 | $544 | $12 |
| Metformin | 18 | $225 | $13 |
| Sulfamethoxazole-Trimethoprim | 46 | $201 | $4 |
| Hydrocodone-Acetaminophen | 16 | $131 | $8 |
| Allopurinol | 12 | $118 | $10 |
2020: 20 drugs
| Myrbetriq | 27 | $22,794 | $844 |
| Elmiron | 14 | $17,811 | $1,272 |
| Alfuzosin Hcl Er | 344 | $11,016 | $32 |
| Tamsulosin | 364 | $8,784 | $24 |
| Silodosin | 51 | $7,997 | $157 |
| Tadalafil | 27 | $6,153 | $228 |
| Estradiol | 28 | $4,810 | $172 |
| Estrace | 12 | $4,275 | $356 |
| Nitrofurantoin Mono-Macro | 71 | $3,589 | $51 |
| Testosterone | 13 | $3,394 | $261 |
| Nitrofurantoin | 24 | $2,219 | $92 |
| Dutasteride | 24 | $1,639 | $68 |
| Progesterone | 22 | $1,047 | $48 |
| Ciprofloxacin | 116 | $684 | $6 |
| Bicalutamide | 20 | $607 | $30 |
| Finasteride | 26 | $562 | $22 |
| Cephalexin | 34 | $394 | $12 |
| Sulfamethoxazole-Trimethoprim | 45 | $228 | $5 |
| Hydrocodone-Acetaminophen | 17 | $177 | $10 |
| Levofloxacin | 18 | $145 | $8 |
2019: 18 drugs
| Myrbetriq | 39 | $33,961 | $871 |
| Elmiron | 11 | $18,899 | $1,718 |
| Alfuzosin Hcl Er | 398 | $12,016 | $30 |
| Silodosin | 62 | $11,875 | $192 |
| Tamsulosin | 362 | $9,678 | $27 |
| Estradiol | 28 | $8,312 | $297 |
| Rapaflo | 16 | $8,083 | $505 |
| Estrace | 14 | $7,246 | $518 |
| Nitrofurantoin Mono-Macro | 62 | $2,791 | $45 |
| Nitrofurantoin | 19 | $1,344 | $71 |
| Dutasteride | 22 | $1,080 | $49 |
| Levofloxacin | 101 | $1,062 | $11 |
| Finasteride | 36 | $1,005 | $28 |
| Bicalutamide | 30 | $871 | $29 |
| Sulfamethoxazole-Trimethoprim | 65 | $338 | $5 |
| Cephalexin | 23 | $331 | $14 |
| Hydrocodone-Acetaminophen | 20 | $191 | $10 |
| Ciprofloxacin | 17 | $125 | $7 |
2018: 18 drugs
| Xtandi | 18 | $198,818 | $11,045 |
| Rapaflo | 108 | $45,336 | $420 |
| Myrbetriq | 74 | $44,147 | $597 |
| Tamsulosin | 432 | $11,716 | $27 |
| Alfuzosin Hcl Er | 388 | $10,429 | $27 |
| Estrace | 15 | $6,965 | $464 |
| Estradiol | 26 | $6,471 | $249 |
| Nitrofurantoin Mono-Macro | 48 | $3,414 | $71 |
| Nitrofurantoin | 26 | $1,479 | $57 |
| Finasteride | 53 | $1,155 | $22 |
| Levofloxacin | 91 | $1,112 | $12 |
| Dutasteride | 17 | $743 | $44 |
| Bicalutamide | 15 | $454 | $30 |
| Sulfamethoxazole-Trimethoprim | 52 | $288 | $6 |
| Cephalexin | 22 | $271 | $12 |
| Insulin | 13 | $158 | $12 |
| Hydrocodone-Acetaminophen | 22 | $137 | $6 |
| Ciprofloxacin | 14 | $96 | $7 |
2017: 20 drugs
| Xtandi | 19 | $190,939 | $10,049 |
| Rapaflo | 140 | $51,626 | $369 |
| Myrbetriq | 55 | $23,119 | $420 |
| Estrace | 38 | $14,993 | $395 |
| Androgel | 24 | $13,354 | $556 |
| Tamsulosin | 435 | $12,616 | $29 |
| Vesicare | 25 | $10,235 | $409 |
| Alfuzosin Hcl Er | 367 | $7,991 | $22 |
| Nitrofurantoin Mono-Macro | 45 | $3,101 | $69 |
| Dutasteride | 34 | $2,315 | $68 |
| Trospium Chloride Er | 15 | $2,281 | $152 |
| Finasteride | 99 | $1,583 | $16 |
| Potassium Citrate Er | 13 | $1,445 | $111 |
| Levofloxacin | 132 | $1,220 | $9 |
| Nitrofurantoin | 14 | $970 | $69 |
| Bicalutamide | 41 | $961 | $23 |
| Oxybutynin Chloride Er | 12 | $623 | $52 |
| Cephalexin | 32 | $431 | $13 |
| Hydrocodone-Acetaminophen | 57 | $266 | $5 |
| Sulfamethoxazole-Trimethoprim | 31 | $149 | $5 |
2016: 21 drugs
| Xtandi | 18 | $164,396 | $9,133 |
| Rapaflo | 265 | $75,197 | $284 |
| Myrbetriq | 48 | $19,207 | $400 |
| Estrace | 56 | $16,285 | $291 |
| Tamsulosin | 379 | $13,626 | $36 |
| Androgel | 22 | $11,829 | $538 |
| Cialis | 30 | $10,160 | $339 |
| Vesicare | 26 | $7,996 | $308 |
| Alfuzosin Hcl Er | 388 | $7,035 | $18 |
| Dutasteride | 43 | $4,223 | $98 |
| Nitrofurantoin Mono-Macro | 58 | $3,673 | $63 |
| Finasteride | 112 | $1,679 | $15 |
| Levofloxacin | 119 | $1,368 | $11 |
| Nitrofurantoin | 17 | $669 | $39 |
| Oxybutynin Chloride Er | 12 | $661 | $55 |
| Bicalutamide | 26 | $621 | $24 |
| Hydrocodone-Acetaminophen | 27 | $330 | $12 |
| Cephalexin | 31 | $288 | $9 |
| Pentoxifylline | 18 | $170 | $9 |
| Allopurinol | 12 | $130 | $11 |
| Sulfamethoxazole-Trimethoprim | 13 | $71 | $5 |
2015: 17 drugs
| Rapaflo | 287 | $64,869 | $226 |
| Tamsulosin | 361 | $17,233 | $48 |
| Vesicare | 53 | $15,931 | $301 |
| Estrace | 58 | $15,412 | $266 |
| Avodart | 38 | $11,970 | $315 |
| Myrbetriq | 33 | $9,743 | $295 |
| Alfuzosin Hcl Er | 315 | $5,567 | $18 |
| Nitrofurantoin Mono-Macro | 45 | $2,289 | $51 |
| Trospium Chloride Er | 11 | $1,774 | $161 |
| Nitrofurantoin | 23 | $1,435 | $62 |
| Bicalutamide | 36 | $1,316 | $37 |
| Levofloxacin | 128 | $1,254 | $10 |
| Finasteride | 103 | $1,118 | $11 |
| Hydrocodone-Acetaminophen | 27 | $325 | $12 |
| Pentoxifylline | 21 | $163 | $8 |
| Allopurinol | 14 | $153 | $11 |
| Cephalexin | 25 | $122 | $5 |
2014: 19 drugs
| Rapaflo | 231 | $45,635 | $198 |
| Vesicare | 101 | $24,002 | $238 |
| Avodart | 47 | $16,149 | $344 |
| Estrace | 68 | $15,438 | $227 |
| Tamsulosin | 330 | $9,449 | $29 |
| Alfuzosin Hcl Er | 309 | $8,681 | $28 |
| Nitrofurantoin Mono-Macro | 51 | $3,234 | $63 |
| Potassium Citrate Er | 13 | $1,580 | $122 |
| Levofloxacin | 119 | $1,342 | $11 |
| Finasteride | 61 | $1,069 | $18 |
| Hydrocodone-Acetaminophen | 33 | $565 | $17 |
| Nitrofurantoin | 14 | $479 | $34 |
| Bicalutamide | 16 | $368 | $23 |
| Pentoxifylline | 25 | $335 | $13 |
| Cephalexin | 27 | $186 | $7 |
| Allopurinol | 23 | $178 | $8 |
| Sulfamethoxazole-Trimethoprim | 13 | $74 | $6 |
| Ciprofloxacin | 12 | $56 | $5 |
| Citalopram Hbr | 12 | $54 | $5 |
2013: 17 drugs
| Rapaflo | 175 | $34,947 | $200 |
| Alfuzosin | 283 | $11,659 | $41 |
| Vesicare | 52 | $11,121 | $214 |
| Avodart | 32 | $8,832 | $276 |
| Estrace | 42 | $8,411 | $200 |
| Enablex | 34 | $7,674 | $226 |
| Tamsulosin | 259 | $6,850 | $26 |
| Nitrofurantoin Mono-Macro | 62 | $5,664 | $91 |
| Toviaz | 16 | $3,555 | $222 |
| Finasteride | 63 | $1,629 | $26 |
| Potassium Citrate | 11 | $1,196 | $109 |
| Levofloxacin | 88 | $735 | $8 |
| Pentoxifylline | 21 | $411 | $20 |
| Hydrocodone-Acetaminophen | 18 | $333 | $18 |
| Allopurinol | 26 | $183 | $7 |
| Cephalexin | 19 | $153 | $8 |
| Sulfamethoxazole-Trimethoprim | 17 | $79 | $5 |
Money from drug and device companies
$3,774 in 2025
| 2025 | 23 | 104 | $1,048 | $3,774 |
| 2024 | 28 | 106 | $16,264 | $20,703 |
| 2023 | 19 | 62 | $958 | $2,626 |
| 2022 | 24 | 98 | $22,644 | $25,117 |
| 2021 | 23 | 74 | $27,328 | $30,691 |
| 2020 | 19 | 50 | $11,236 | $12,998 |
| 2019 | 21 | 141 | $25,385 | $33,162 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| KARL STORZ Endoscopy-America | Autocon | $1,048 | 1 payment
|
| Sumitomo Pharma America | Gemtesa | $973 | 33 payments
|
| Ferring Pharmaceuticals | Adstiladrin | $255 | 7 payments
|
| Abbvie | Botox | $213 | 10 payments
|
| AstraZeneca Pharmaceuticals LP | Lynparza | $199 | 6 payments
|
| Accord Healthcare | Camcevi | $143 | 8 payments
|
See all 100 published payments
| Sumitomo Pharma America | Meals · 2025-12-22 | Gemtesa | $8 |
| Sumitomo Pharma America | Meals · 2025-12-19 | Gemtesa | $32 |
| Dendreon Pharmaceuticals | Meals · 2025-12-18 | Provenge | $33 |
| Sumitomo Pharma America | Meals · 2025-12-12 | Gemtesa | $40 |
| Abbvie | Meals · 2025-12-11 | Lupron Depot | $14 |
| Abbvie | Meals · 2025-12-09 | Botox | $26 |
| Accord Healthcare | Meals · 2025-12-09 | Camcevi | $6 |
| Sumitomo Pharma America | Meals · 2025-12-03 | Gemtesa | $38 |
| Sumitomo Pharma America | Meals · 2025-11-21 | Gemtesa | $40 |
| Verity Pharmaceuticals | Meals · 2025-11-17 | Tlando | $18 |
| Coloplast | Meals · 2025-11-11 | Luja Coude | $22 |
| Sumitomo Pharma America | Meals · 2025-11-06 | Gemtesa | $15 |
| Sumitomo Pharma America | Meals · 2025-11-02 | Gemtesa | $45 |
| Sumitomo Pharma America | Meals · 2025-10-30 | Gemtesa | $18 |
| Janssen Biotech | Meals · 2025-10-28 | Erleada | $31 |
| Sumitomo Pharma America | Meals · 2025-10-24 | Gemtesa | $38 |
| KARL STORZ Endoscopy-America | Consulting · 2025-10-17 | Autocon | $1,048 |
| Sumitomo Pharma America | Meals · 2025-10-16 | Gemtesa | $36 |
| Novartis Pharmaceuticals | Meals · 2025-10-16 | Pluvicto | $19 |
| Sumitomo Pharma America | Meals · 2025-10-09 | Gemtesa | $36 |
| Verity Pharmaceuticals | Meals · 2025-10-07 | Tlando | $24 |
| Ferring Pharmaceuticals | Meals · 2025-10-06 | Adstiladrin | $28 |
| Accord Healthcare | Meals · 2025-10-01 | Camcevi | $24 |
| Sumitomo Pharma America | Meals · 2025-09-26 | Gemtesa | $11 |
| Accord Healthcare | Meals · 2025-09-23 | Camcevi | $8 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-09-16 | None | $28 |
| Procept Biorobotics | Meals · 2025-09-16 | Aquabeam Robotic System | $38 |
| Sumitomo Pharma America | Meals · 2025-09-11 | Gemtesa | $13 |
| AngioDynamics | Meals · 2025-09-11 | Nanoknife | $35 |
| Verity Pharmaceuticals | Meals · 2025-09-09 | Tlando | $16 |
| Abbvie | Meals · 2025-09-08 | Lupron Depot | $21 |
| Sumitomo Pharma America | Meals · 2025-09-05 | Gemtesa | $38 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-09-02 | Nubeqa | $22 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-08-29 | None | $34 |
| Accord Healthcare | Meals · 2025-08-29 | Camcevi | $6 |
| Progenics Pharmaceuticals | Meals · 2025-08-26 | Pylarify | $26 |
| Ferring Pharmaceuticals | Meals · 2025-08-23 | Adstiladrin | $16 |
| Novartis Pharmaceuticals | Meals · 2025-08-14 | Pluvicto | $19 |
| Sumitomo Pharma America | Meals · 2025-08-13 | Gemtesa | $38 |
| Verity Pharmaceuticals | Meals · 2025-08-13 | Tlando | $23 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-08-12 | None | $32 |
| Astellas Pharma US | Meals · 2025-08-12 | Xtandi | $25 |
| Abbvie | Meals · 2025-08-06 | Botox | $32 |
| Abbvie | Meals · 2025-08-01 | Lupron Depot | $4 |
| Sumitomo Pharma America | Meals · 2025-07-31 | Gemtesa | $35 |
| Antares Pharma | Meals · 2025-07-24 | Xyosted | $27 |
| Sumitomo Pharma America | Meals · 2025-07-22 | Gemtesa | $14 |
| Abbvie | Meals · 2025-07-21 | Lupron Depot | $19 |
| Verity Pharmaceuticals | Meals · 2025-07-21 | Tlando | $18 |
| Accord Healthcare | Meals · 2025-07-17 | Camcevi | $26 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-07-11 | None | $22 |
| Sumitomo Pharma America | Meals · 2025-07-09 | Gemtesa | $36 |
| Teleflex | Meals · 2025-07-09 | Barrigel | $65 |
| Progenics Pharmaceuticals | Meals · 2025-07-09 | Pylarify | $21 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-07-08 | None | $26 |
| Ferring Pharmaceuticals | Meals · 2025-06-30 | Adstiladrin | $19 |
| Sumitomo Pharma America | Meals · 2025-06-29 | Gemtesa | $10 |
| Coloplast | Meals · 2025-06-24 | Luja Coude | $17 |
| Sumitomo Pharma America | Meals · 2025-06-19 | Gemtesa | $30 |
| Sumitomo Pharma America | Meals · 2025-06-09 | Gemtesa | $16 |
| Endo USA | Meals · 2025-06-08 | Xiaflex | $29 |
| Novartis Pharmaceuticals | Meals · 2025-06-05 | Pluvicto | $32 |
| Accord Healthcare | Meals · 2025-06-04 | Camcevi | $22 |
| Sumitomo Pharma America | Meals · 2025-05-28 | Gemtesa | $39 |
| Abbvie | Meals · 2025-05-21 | Botox | $25 |
| Sumitomo Pharma America | Meals · 2025-05-16 | Gemtesa | $17 |
| Agiliti Surgical | Meals · 2025-05-13 | Sonablate Hifu | $22 |
| Ferring Pharmaceuticals | Meals · 2025-05-12 | Adstiladrin | $21 |
| Sumitomo Pharma America | Meals · 2025-05-09 | Gemtesa | $31 |
| Janssen Biotech | Meals · 2025-05-08 | Erleada | $13 |
| Janssen Biotech | Meals · 2025-05-07 | Erleada | $28 |
| Sumitomo Pharma America | Meals · 2025-05-02 | Gemtesa | $41 |
| Sumitomo Pharma America | Meals · 2025-04-25 | Gemtesa | $41 |
| Ferring Pharmaceuticals | Meals · 2025-04-25 | Adstiladrin | $134 |
| Novartis Pharmaceuticals | Meals · 2025-04-22 | Pluvicto | $34 |
| Abbvie | Meals · 2025-04-18 | Botox | $24 |
| Coloplast | Meals · 2025-04-15 | Luja Coude | $17 |
| Progenics Pharmaceuticals | Meals · 2025-04-14 | Pylarify | $15 |
| Sumitomo Pharma America | Meals · 2025-04-07 | Gemtesa | $39 |
| Ferring Pharmaceuticals | Meals · 2025-04-07 | Adstiladrin | $17 |
| Accord Healthcare | Meals · 2025-04-03 | Camcevi | $24 |
| Astellas Pharma US | Meals · 2025-03-31 | Xtandi | $21 |
| Sumitomo Pharma America | Meals · 2025-03-26 | Gemtesa | $26 |
| Abbvie | Meals · 2025-03-24 | Botox | $23 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-03-24 | Nubeqa | $27 |
| ConvaTec | Meals · 2025-03-21 | Gentlecath | $23 |
| Sumitomo Pharma America | Meals · 2025-03-19 | Gemtesa | $42 |
| Janssen Biotech | Meals · 2025-03-18 | Erleada | $25 |
| Telix Pharmaceuticals | Meals · 2025-03-14 | Illuccix | $26 |
| Sumitomo Pharma America | Meals · 2025-03-12 | Gemtesa | $40 |
| Telix Pharmaceuticals | Meals · 2025-03-02 | Illuccix | $20 |
| Sumitomo Pharma America | Meals · 2025-02-27 | Gemtesa | $26 |
| Accord Healthcare | Meals · 2025-02-19 | Camcevi | $27 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-02-18 | Lynparza | $57 |
| Sumitomo Pharma America | Meals · 2025-02-14 | Gemtesa | $36 |
| Astellas Pharma US | Meals · 2025-02-11 | Xtandi | $20 |
| Abbvie | Meals · 2025-02-04 | Lupron Depot | $24 |
| Ferring Pharmaceuticals | Meals · 2025-01-23 | Adstiladrin | $20 |
| Sumitomo Pharma America | Meals · 2025-01-14 | Gemtesa | $9 |
| Profound Medical | Meals · 2025-01-07 | Tulsa-Pro | $91 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $20,703
| Arthrex | None | $11,409 | 14 payments
|
| Stryker | Iconix | $4,988 | 2 payments
|
| Medical Device Business Services | Certus 140 | $1,768 | 1 payment
|
| Dendreon Pharmaceuticals | Provenge | $583 | 14 payments
|
| Sumitomo Pharma America | Gemtesa | $426 | 16 payments
|
| Endo Pharmaceuticals | Xiaflex | $196 | 3 payments
|
| AstraZeneca Pharmaceuticals LP | Lynparza | $163 | 7 payments
|
| Blue Earth Diagnostics | Posluma | $142 | 6 payments
|
| Astellas Pharma US | Myrbetriq | $129 | 3 payments
|
| Accord Healthcare | Camcevi | $111 | 5 payments
|
| Teleflex | Urolift | $103 | 2 payments
|
| Abbvie | Lupron Depot | $80 | 4 payments
|
| Immunitybio | Anktiva | $63 | 2 payments
|
| Pfizer | Xtandi | $62 | 3 payments
|
| Edap Technomed | None | $60 | 3 payments
|
| Coloplast | Luja Coude | $57 | 2 payments
|
| Janssen Biotech | Erleada | $56 | 3 payments
|
| Olympus America | Itind System | $51 | 2 payments
|
| Bayer Healthcare Pharmaceuticals | Nubeqa | $35 | 2 payments
|
| ConvaTec | Gentlecath | $32 | 1 payment
|
| Axonics | Axonics | $30 | 1 payment
|
| PROCEPT BioRobotics | Aquabeam System | $27 | 1 payment
|
| US Oncology Corporate | None | $27 | 1 payment
|
| Laborie Medical Technologies | Optilume Bph Drug Coated Balloon Catheter | $26 | 1 payment
|
| Endo USA | Xiaflex | $24 | 1 payment
|
| Intuitive Surgical | Da Vinci Surgical System | $21 | 1 payment
|
| Novartis Pharmaceuticals | Pluvicto | $20 | 1 payment
|
| Antares Pharma | Xyosted | $15 | 1 payment
|
2023: $2,626
| Bayer Healthcare Pharmaceuticals | Nubeqa | $976 | 2 payments
|
| Sumitomo Pharma America | Gemtesa | $273 | 10 payments
|
| Astellas Pharma US | Myrbetriq | $260 | 13 payments
|
| Dendreon Pharmaceuticals | Provenge | $227 | 7 payments
|
| Agiliti Surgical | Sonablate | $172 | 2 payments
|
| Endo Pharmaceuticals | Aveed | $113 | 5 payments
|
| Amgen | Xgeva | $103 | 3 payments
|
| Accord Healthcare | Camcevi | $96 | 4 payments
|
| Profound Medical | Tulsa-Pro | $65 | 1 payment
|
| Abbvie | Lupron Depot | $57 | 3 payments
|
| Pfizer | Xtandi | $52 | 3 payments
|
| Janssen Biotech | Erleada | $50 | 2 payments
|
| Ethicon US | Vistaseal | $38 | 1 payment
|
| Myriad Genetic Laboratories | Prolaris | $31 | 1 payment
|
| Tolmar | Jatenzo | $28 | 1 payment
|
| Coloplast | Speedicath | $28 | 1 payment
|
| Progenics Pharmaceuticals | Pylarify | $20 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Lynparza | $20 | 1 payment
|
| Supernus Pharmaceuticals | Xyosted | $16 | 1 payment
|
2022: $25,117
| Stryker | Iris | $16,948 | 14 payments
|
| Medical Device Business Services | Certus 140 | $3,788 | 2 payments
|
| Ethicon | Certus 140 | $2,525 | 1 payment
|
| Astellas Pharma US | Myrbetriq | $442 | 20 payments
|
| Dendreon Pharmaceuticals | Provenge | $328 | 14 payments
|
| Urovant Sciences | Gemtesa | $238 | 8 payments
|
| Antares Pharma | Nocdurna | $153 | 7 payments
|
| Endo Pharmaceuticals | Xiaflex | $91 | 4 payments
|
| Teleflex | Urolift System | $90 | 2 payments
|
| Janssen Biotech | Erleada | $59 | 3 payments
|
| Amgen | Xgeva | $58 | 2 payments
|
| Accord Healthcare | Camcevi | $54 | 3 payments
|
| Progenics Pharmaceuticals | Pylarify | $49 | 2 payments
|
| Hollister | Onli | $41 | 2 payments
|
| UroGen Pharma | Jelmyto | $39 | 2 payments
|
| Allergan | Botox | $34 | 2 payments
|
| Kowa Pharmaceuticals America | Seglentis | $29 | 2 payments
|
| Bayer HealthCare Pharmaceuticals | Nubeqa | $29 | 2 payments
|
| Abbvie | Lupron Depot | $27 | 1 payment
|
| Myriad Genetic Laboratories | Brac Cdx | $21 | 1 payment
|
| 180 Medical | Cure Catheter | $21 | 1 payment
|
| TOLMAR Pharmaceuticals | Eligard | $19 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Lynparza | $17 | 1 payment
|
| Blue Earth Diagnostics | Axumin | $17 | 1 payment
|
2021: $30,691
| Stryker | Iris | $26,741 | 24 payments
|
| Medical Device Business Services | Certus 140 | $2,778 | 1 payment
|
| Astellas Pharma US | Xtandi | $336 | 13 payments
|
| Janssen Biotech | Erleada | $210 | 7 payments
|
| Amgen | Prolia | $83 | 3 payments
|
| Urovant Sciences | Gemtesa | $81 | 3 payments
|
| Pfizer | Xtandi | $66 | 2 payments
|
| 180 Medical | Gentlecath | $59 | 3 payments
|
| Dendreon Pharmaceuticals | Provenge | $44 | 2 payments
|
| Bayer HealthCare Pharmaceuticals | Nubeqa | $39 | 2 payments
|
| Myovant Sciences | Orgovyx | $33 | 2 payments
|
| AbbVie | Lupron Depot | $23 | 1 payment
|
| TOLMAR Pharmaceuticals | Eligard | $23 | 1 payment
|
| Progenics Pharmaceuticals | Pylarify | $22 | 1 payment
|
| Urogen Pharma | Jelmyto | $21 | 1 payment
|
| Antares Pharma | Xyosted | $20 | 1 payment
|
| EMD Serono | None | $19 | 1 payment
|
| Hollister | Vapro | $17 | 1 payment
|
| AngioDynamics | Nanoknife | $17 | 1 payment
|
| Axonics | Axonics R-Snm System | $17 | 1 payment
|
| Clarus Therapeutics | Jatenzo | $17 | 1 payment
|
| Allergan | Botox | $12 | 1 payment
|
| Blue Earth Diagnostics | Axumin | $12 | 1 payment
|
2020: $12,998
| Arthrex | None | $5,346 | 4 payments
|
| Astellas Pharma US | Xtandi | $4,141 | 15 payments
|
| Stryker | 1188 Hd Autoclavable Camera | $2,997 | 5 payments
|
| NeoTract | Urolift | $72 | 2 payments
|
| 180 Medical | Speedicath | $70 | 4 payments
|
| Coloplast | Speedicath | $48 | 3 payments
|
| Ethicon US | Vistaseal | $42 | 1 payment
|
| Amgen | Prolia | $38 | 2 payments
|
| Zyla Life Sciences | Sprix | $36 | 2 payments
|
| Pfizer | Xtandi | $32 | 1 payment
|
| Janssen Biotech | Erleada | $27 | 2 payments
|
| Foundation Medicine | Foundationone | $24 | 1 payment
|
| Assertio Therapeutics | Zipsor | $24 | 2 payments
|
| Bayer HealthCare Pharmaceuticals | Nubeqa | $22 | 1 payment
|
| AngioDynamics | None | $18 | 1 payment
|
| TOLMAR Pharmaceuticals | Eligard | $17 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Lynparza | $17 | 1 payment
|
| Photocure | Cysview | $15 | 1 payment
|
| Myriad Genetic Laboratories | Bracanalysis Cdx | $13 | 1 payment
|
2019: $33,162
| Stryker | Ukit | $23,898 | 15 payments
|
| Astellas Pharma US | Xtandi | $3,055 | 16 payments
|
| Pfizer | Xtandi | $2,203 | 21 payments
|
| NeoTract | Urolift | $1,331 | 8 payments
|
| Arthrex | None | $1,243 | 10 payments
|
| Dendreon Pharmaceuticals | Provenge | $408 | 9 payments
|
| Janssen Biotech | Erleada | $224 | 21 payments
|
| Amgen | Prolia | $179 | 7 payments
|
| Endo Pharmaceuticals | Xiaflex | $136 | 4 payments
|
| Ferring Pharmaceuticals | Firmagon | $62 | 3 payments
|
| Coloplast | Speedicath | $60 | 4 payments
|
| 180 Medical | Gentlecath | $57 | 4 payments
|
| Zyla Life Sciences | Zorvolex | $55 | 3 payments
|
| TOLMAR Pharmaceuticals | Eligard | $43 | 2 payments
|
| TherapeuticsMD | Imvexxy | $41 | 2 payments
|
| Antares Pharma | Xyosted | $34 | 2 payments
|
| Allergan | Botox | $33 | 2 payments
|
| Bayer HealthCare Pharmaceuticals | Nubeqa | $33 | 2 payments
|
| AbbVie | Lupron Depot | $24 | 1 payment
|
| Boston Scientific | General Bph | $24 | 1 payment
|
| Photocure | Cysview | $18 | 1 payment
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| Siemens Medical Solutions USA, Inc. · Psaii and Fpsaii Collection Study · 2019 | Their institution | $7,848 |
| Siemens Medical Solutions USA, Inc. · Specimen Collection of Monitoring Samples at Urology Practices for Hspsa Assay Multiplatform-201801.Pro · 2021 | Their institution | $1,325 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 75.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1932272804
- Licence
- CA A65099California A65099: Current · expires 2028-01-31
- Trained
- Boston University School of Medicine, 1996
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Urology (208800000X); Federal specialty code 2088P0231X (2088P0231X)
- Mailing address
- 2460 Samaritan Dr, San Jose, CA, 95124
- NPI first listed
- 2006-11-16
- NPI last updated
- 2019-10-25
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 2581 Samaritan Dr, San Jose, CA, 95124
This office lists an electronic records connection.